Profiles

Keywords
Last Name
Institution

Marta Batus

Concepts (115)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antineoplastic Agents
8
2016
292
2.370
Why?
Carcinoma, Non-Small-Cell Lung
12
2018
347
1.730
Why?
Lung Neoplasms
12
2018
707
1.440
Why?
Molecular Targeted Therapy
3
2013
37
1.240
Why?
Antibodies, Monoclonal
4
2016
305
0.990
Why?
Sarcoma
3
2019
83
0.910
Why?
Antineoplastic Combined Chemotherapy Protocols
6
2019
365
0.840
Why?
Immunotherapy
2
2013
63
0.740
Why?
Medical Oncology
1
2016
36
0.730
Why?
Chemoradiotherapy
4
2019
64
0.690
Why?
ErbB Receptors
4
2018
72
0.600
Why?
Melanoma
1
2013
60
0.580
Why?
Bone Neoplasms
1
2013
103
0.550
Why?
Carcinoma, Squamous Cell
4
2018
186
0.370
Why?
Drug Resistance, Neoplasm
2
2018
63
0.330
Why?
Neoplasm Recurrence, Local
2
2016
175
0.320
Why?
Receptor, IGF Type 1
2
2013
18
0.290
Why?
Quinazolines
2
2012
26
0.280
Why?
Prognosis
6
2018
864
0.270
Why?
Humans
20
2019
26074
0.270
Why?
Neoplasm Staging
7
2016
465
0.240
Why?
Adenocarcinoma
3
2018
221
0.240
Why?
Retrospective Studies
10
2019
2661
0.230
Why?
Inflammation Mediators
1
2018
80
0.200
Why?
Female
15
2019
15514
0.200
Why?
Palliative Care
2
2015
104
0.200
Why?
Treatment Outcome
7
2019
3258
0.190
Why?
Male
14
2019
15162
0.190
Why?
Gene Dosage
2
2012
26
0.170
Why?
Protein Kinase Inhibitors
2
2018
58
0.170
Why?
Neoplasm Metastasis
2
2013
132
0.170
Why?
Aged
10
2019
8625
0.160
Why?
Survival Rate
4
2018
396
0.160
Why?
Radiotherapy, Conformal
1
2014
24
0.160
Why?
Neoplasms
1
2016
223
0.160
Why?
Cancer Vaccines
1
2013
19
0.150
Why?
Angiogenesis Inhibitors
1
2013
25
0.150
Why?
Mutation
2
2018
417
0.150
Why?
Adult
6
2019
8550
0.150
Why?
Forecasting
1
2013
121
0.150
Why?
Weight Gain
1
2012
59
0.140
Why?
Middle Aged
10
2019
9801
0.140
Why?
Follow-Up Studies
5
2018
1798
0.140
Why?
PTEN Phosphohydrolase
1
2011
13
0.140
Why?
Phosphatidylinositol 3-Kinases
1
2011
51
0.130
Why?
Survival Analysis
4
2015
362
0.130
Why?
Gene Amplification
1
2010
27
0.130
Why?
Child, Preschool
1
2013
728
0.130
Why?
Rectal Neoplasms
1
2010
20
0.130
Why?
Xanthine Dehydrogenase
1
2010
7
0.130
Why?
Pyrimidines
1
2010
26
0.130
Why?
Gastrointestinal Stromal Tumors
1
2010
12
0.120
Why?
Young Adult
2
2016
1849
0.120
Why?
Adolescent
2
2016
2327
0.120
Why?
Gene Expression Regulation, Neoplastic
1
2010
116
0.120
Why?
Piperazines
1
2010
85
0.120
Why?
United States
1
2016
2029
0.120
Why?
Lymphohistiocytosis, Hemophagocytic
1
2008
6
0.110
Why?
Child
1
2013
1347
0.110
Why?
Clinical Trials as Topic
1
2010
365
0.110
Why?
Chromosomes, Human, Pair 10
1
2007
6
0.100
Why?
Chromosomes, Human, Pair 3
1
2007
7
0.100
Why?
Chromosomes, Human, Pair 1
1
2007
13
0.100
Why?
Receptor, ErbB-2
1
2007
39
0.100
Why?
Carcinoma, Large Cell
2
2018
18
0.090
Why?
Animals
2
2013
4855
0.090
Why?
Neoadjuvant Therapy
2
2019
57
0.080
Why?
Kaplan-Meier Estimate
2
2017
195
0.080
Why?
Carboplatin
2
2015
48
0.080
Why?
Etoposide
2
2015
65
0.080
Why?
Paclitaxel
2
2015
72
0.080
Why?
Aged, 80 and over
4
2018
4397
0.080
Why?
Breast Neoplasms
1
2007
399
0.070
Why?
Cohort Studies
2
2015
1575
0.060
Why?
Mesna
1
2019
4
0.060
Why?
Ifosfamide
1
2019
14
0.060
Why?
Organ Sparing Treatments
1
2019
9
0.060
Why?
Arm
1
2019
47
0.060
Why?
Doxorubicin
1
2019
71
0.060
Why?
Leg
1
2019
46
0.050
Why?
Proteomics
1
2018
38
0.050
Why?
Leukocyte Count
1
2017
84
0.050
Why?
Taxoids
1
2016
16
0.050
Why?
Tomography, X-Ray Computed
2
2014
807
0.050
Why?
Deoxycytidine
1
2016
42
0.050
Why?
Lymphocytes
1
2017
107
0.050
Why?
Body Weight
1
2017
152
0.050
Why?
Radiation Pneumonitis
1
2015
4
0.050
Why?
Hemoptysis
1
2015
9
0.050
Why?
Esophagitis
1
2015
11
0.050
Why?
Cough
1
2015
12
0.050
Why?
Neutrophils
1
2017
127
0.050
Why?
Chest Pain
1
2015
20
0.050
Why?
Dyspnea
1
2015
26
0.050
Why?
Chemoradiotherapy, Adjuvant
1
2015
19
0.050
Why?
Radiation Injuries
1
2015
41
0.040
Why?
Disease-Free Survival
1
2015
213
0.040
Why?
Mobility Limitation
1
2015
75
0.040
Why?
Radiotherapy Dosage
1
2014
145
0.040
Why?
Diet
1
2015
165
0.040
Why?
Radiotherapy Planning, Computer-Assisted
1
2014
73
0.040
Why?
Prospective Studies
1
2018
1544
0.040
Why?
Class I Phosphatidylinositol 3-Kinases
1
2011
11
0.030
Why?
Activities of Daily Living
1
2015
404
0.030
Why?
Benzamides
1
2010
11
0.030
Why?
Immunohistochemistry
1
2012
466
0.030
Why?
Colectomy
1
2010
33
0.030
Why?
Quality of Life
1
2015
515
0.030
Why?
Combined Modality Therapy
1
2011
445
0.030
Why?
Biopsy
1
2010
263
0.030
Why?
Smoking
1
2010
168
0.030
Why?
Signal Transduction
1
2012
520
0.030
Why?
Fatal Outcome
1
2008
70
0.030
Why?
Risk Assessment
1
2011
697
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2007
116
0.020
Why?
Batus's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description